FDA Requires Additional Labeling For Over-the-Counter Pain Relievers And Fever Reducers To Help Consumers Use Products Safely The Food and Drug Administration issued a final rule today that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks, such as internal bleeding and liver damage, associated with the use of these popular drugs.
Source: www.medicalnewstoday.comPharmaMar Presented At AACR 14 New Studies On Its Marine-derived Antitumour Compounds PharmaMar, a biopharmaceutical company of Zeltia Group, ZEL.MC presented the results of 14 new studies on its pipeline of antitumor compounds of marine origin at the 100th Congress of the Annual Conference of the American Association for Cancer Research (AACR), held in Denver, 18-22 April.
Source: www.medicalnewstoday.comAutism And Genes, More Compelling Evidence Of Links Three new genome-wide association studies bring together the most compelling evidence to date that genes and autism are linked. The studies scanned and compared the entire set of human DNA of people who have an autism spectrum disorder (ASD) with that of people who do not and found small genetic differences that affect the way brain cells link up to make the circuitry of a child's brain.
Source: www.medicalnewstoday.comMore Americans seen failing to fill prescriptions. The Wall Street Journal (4/8, Rockoff) reports, “More Americans are failing to fill prescriptions because of the economic downturn, according to market research” from health-information company Wolters Kluwer Health. “
Prescription-drug sales are usually immune to the economy’s ups and downs, but the data…indicate that the current recession is having an unusually negative impact.” The research [...]
Source: feedproxy.google.com
# posted by Network @ 12:37 AM
